Combination therapy for tumors with MR-guided focused ultrasound and radiotherapy
ICCAS’ research team around the SONO-RAY joint project recently published their study results in Springer Medicine’s Journal “Strahlentherapie und Onkologie”. The paper examines the tumor radiosensitization effect at the cellular level following combination treatment with focused ultrasound (FUS) and radiotherapy, and is freely available to the research community and the public as open access here. The in vitro results show that FUS has good potential to sensitize glioblastoma and prostate cancer cells to radiotherapy, mainly by enhancing the DNA damage to cancer cells. You can find more information about the SONO-RAY joint project with our partners from the National Center for Radiation Research in Oncology (OncoRay) here.